Background: Serine/arginine protein kinase 1 (SRPK1) is a protein kinase that belongs to the serine/arginine-rich domain family of splicing factors which are essential for splice-site selection, especially the modulation for RNA metabolism, localization, and translation. High expression of SRPK1 has been found in numerous human cancers, but its mechanism in colorectal cancer (CRC) is still rarely reported.

Purpose: To investigate the expression of SRPK1 in CRC tissues and cells and determine its functions and mechanism in CRC.

Methods: The expression of SRPK1 was explored in human CRC patients and cells by immunohistochemistry, real-time quantitative PCR, and Western blot; Cell Counting Kit-8, Transwell, flow cytometry, and tube formation assay were used to investigate the CRC cell viability, migration, apoptosis, and angiogenesis, respectively.

Results: SRPK1 was overexpressed in CRC tumor tissues and cells, and correlated with tumor node metastasis stage; inhibition of SRPK1 by siRNA resulted in decreased cell growth and migration, significantly increased apoptosis, and suppressed angiogenesis.

Conclusion: SRPK1 can be a prognostic indicator of CRC and may be a therapeutic target for CRC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128266PMC
http://dx.doi.org/10.2147/OTT.S172541DOI Listing

Publication Analysis

Top Keywords

expression srpk1
12
srpk1
8
prognostic indicator
8
therapeutic target
8
colorectal cancer
8
protein kinase
8
tissues cells
8
crc
7
srpk1 poor
4
poor prognostic
4

Similar Publications

Background: Diabetic retinopathy (DR) is the most important complication of Type 2 Diabetes (T2D) in eyes. Despite its prevalence, the early detection and management of DR continue to pose considerable challenges. Our research aims to elucidate potent drug targets that could facilitate the identification of DR and propel advancements in its therapeutic strategies.

View Article and Find Full Text PDF

Aberrant FAM135B attenuates the efficacy of chemotherapy in colorectal cancer by modulating SRSF1-mediated alternative splicing.

Oncogene

November 2024

Department of Pathology, Guangdong Province Key Laboratory of Molecular Tumor Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.

Article Synopsis
  • * The gene FAM135B is frequently mutated in CRC, plays a key role in cancer cell growth, and contributes to the resistance against oxaliplatin by influencing a process called alternative splicing through the protein SRSF1.
  • * Targeting FAM135B could be a promising new approach to improve treatment outcomes for patients with colorectal cancer.
View Article and Find Full Text PDF
Article Synopsis
  • Cholangiocarcinoma (CCA) is a bile duct cancer prevalent in Thailand, characterized by poor prognosis and low survival rates due to challenges in early detection and treatment.
  • The study explores the role of serine/arginine protein kinases (SRPKs) in CCA, specifically how their hyperphosphorylation affects splicing factors linked to cancer-related mRNA errors.
  • Results indicate that high levels of SRPK1 correlate with shorter patient survival and that SRPK inhibitors increase cell death in CCA cell lines, revealing potential targets for new treatments.
View Article and Find Full Text PDF

Epsilon toxin (ETX), a potential agent of biological and toxic warfare, causes the death of many ruminants and threatens human health. It is crucial to understand the toxic mechanism of such a highly lethal and rapid course toxin. In this study, we detected the effects of ETX on the proteome and phosphoproteome of MDCK cells after 10 min and 30 min.

View Article and Find Full Text PDF

Background: Kawasaki disease (KD) is a systemic vasculitis primarily affecting the coronary arteries in children. Despite growing attention to its symptoms and pathogenesis, the exact mechanisms of KD remain unclear. Mitophagy plays a critical role in inflammation regulation, however, its significance in KD has only been minimally explored.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!